HIV Diagnostics Test Market Expected to Grow US$ 8,487.17 Million by 2030 with CAGR of 9.0% | Coherent Market Insights

The global HIV diagnostics test market is estimated to be valued at US$ 4,263.62 million in 2022 and expected to reach US$ 8,487.17 million by 2030, witnessing a CAGR of 9.0% over the forecast period (2022-2030). HIV weakens the immune system. Untreated HIV affects CD4 cells, which eventually gets deteriorate. As more CD4 cells are lost to HIV, the body becomes more vulnerable to contracting other illnesses and cancers. Blood tests most frequently are used for HIV diagnoses. These tests search for the virus-specific antibodies that the body produces to combat the virus. Even though it might take the body anywhere from six weeks to a year to acquire antibodies to the virus, anyone exposed to it should get tested every once. Depending on the initial period of exposure, more tests might be required. Patients with clinical signs and symptoms of acute or chronic infection and those who may have been exposed to HIV should undergo HIV testing to be diagnosed with the virus.

Ask For A Sample Copy Report @ https://www.coherentmarketinsights.com/insight/request-sample/422

Some of the Top Players in HIV Diagnostics Test Market: 

Abbott, Bio-Rad Laboratories, Inc., Hologic, Inc., Siemens Healthineers, Roche AG, Beckman Coulter Inc., OraSure Technologies, Inc., Becton, Dickinson and Company, Merck KGaA, Chembio Diagnostic Systems, Inc., Zyomyx Incorporation, Bristol –Myers Squibb, Janssen Pharmaceutica NV, QIAGEN N.V., and ViiV Healthcare Ltd.

The HIV Diagnostics Test Market involves the diagnosis and monitoring of HIV infection in individuals. These tests play a crucial role in identifying the presence of HIV antibodies or antigens in the blood, saliva, or urine samples of affected individuals. The rising prevalence of HIV/AIDS, particularly in low- and middle-income countries, is driving the demand for accurate and efficient diagnosis of the infection. HIV diagnostics tests include rapid tests, ELISA assays, nucleic acid tests, and Western blot tests. These tests are used in various settings such as hospitals, diagnostic laboratories, blood banks, and home care settings. They aid in disease management, prevention of mother-to-child transmission, and screening of blood and organ donations.

Detailed Segmentation:

• Global HIV Diagnostics Test Market, By Test Type:
  • Screening
    • Third Generation (Antibody Test)
      • Laboratory-based
      • Point-of-Care
    • Fourth Generation (Antibody Test)
      • Laboratory-based
      • Point-of-Care
    • Others
  • Differentiation & Confirmation Test
  • Monitoring Test
    • CD4 Test
    • Viral Load Tests

Market Dynamics:

Drivers

• Rise in the prevalence of sexually transmitted diseases

The number of infected people is still rising throughout many decades of the HIV pandemic. The socioeconomic factors that underlie this ongoing rise also point to a failure in preventative efforts. There are more than 20 million estimated new instances of sexually transmitted diseases in the United States each year, and the rates are rising despite though many of these infections are avoidable. Moreover, more than 1.2 million HIV-positive people are living in the U.S. Efforts to promote sexually transmitted diseases testing, and screening can determine a person’s risk of contracting them and assist those who already have one in receiving treatment, improving their health and reducing the likelihood that HIV will spread to others. In 2021, there were about 38.4 million HIV-positive individuals worldwide. Almost 54% of these were women and girls.

Buy Now and Get a Discount on this Report @ https://www.coherentmarketinsights.com/insight/buy-now/422

Restraints:

• Complexity in the testing window period

The window period is one of the most significant issues with HIV testing. A negative test result can indicate that a person has recently become HIV-positive. The window of testing is crucial in determining the actual results of the person. Thus, this complexity hampers the growth of the HIV diagnosis market.

Opportunities:

• Rising initiatives by global agencies for curbing the cases

One of the most critical public health issues in the world is HIV. Thus there is an international commitment to halting new HIV infections and providing access to treatment for HIV to everyone around the globe. WHO advises getting tested for HIV for everyone who may be at risk. In the early stages of the crisis, the World Bank pioneered worldwide finance for HIV/AIDS and has given US$4.6 billion since 1989 for initiatives connected to the disease. Around 7 million people have been tested for HIV due to funding from the Bank, specifically through the International Development Association, for 1,500 counselling and testing facilities.

Table of Contents with Major Points:

Executive Summary

• Introduction
• Key Findings
• Recommendations
• Definitions and Assumptions

Executive Summary

Market Overview

• Definition of HIV Diagnostics Test Market
• Market Dynamics
• Drivers
• Restraints
• Opportunities
• Trends and Developments

Key Insights

• Key Emerging Trends
• Key Developments Mergers and Acquisition
• New Product Launches and Collaboration
• Partnership and Joint Venture
• Latest Technological Advancements
• Insights on Regulatory Scenario
• Porters Five Forces Analysis

Qualitative Insights Impact of COVID-19 on Global HIV Diagnostics Test Market

• Supply Chain Challenges
• Steps taken by Government/Companies to overcome this impact
• Potential opportunities due to COVID-19 outbreak

Conclusion 

Appendix

• Data Sources
• Abbreviations
• Disclaimer

TOC Continued…!

Customize Your Report Now @ https://www.coherentmarketinsights.com/insight/request-customization/422

Check Out More Report:

LATAM Fabry Disease Market

Skin Fibrosis Treatment Market

Scopolamine API Market

Digital Biomanufacturing Market

Pulmonary Surfactant Market

Preclinical Assets Market

Dermatomyositis Drug Market

China Mesalazine Market

Dry Eye Disease Market

Glycopeptide Antibiotics Market